Inhibition of hepatitis B virus replication by Bay 41-4109 and its association with nucleocapsid disassembly

Journal of Chemotherapy

Volumn 20, Issue 4, 2008, Pages 458-467

  Wu, Guo Yi ^a   Zheng, Xiao Jing ^b   Yin, Chang Cheng ^b   Jiang, Dong ^a   Zhu, Ling ^a   Liu, Yan ^a   Wei, Lai ^a   Wang, Yu ^a   Chen, Hong Song ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Antiviral effects; Bay 41 4109; Core protein; HBV DNA; Hepatitis B

Indexed keywords

ANTIVIRUS AGENT; BAY 41 4109; DIMER; HEPATITIS B CORE ANTIGEN; LAMIVUDINE; METHYL 4 (2 CHLORO 4 FLUOROPHENYL) 2 (3,5 DIFLUORO 2 PYRIDINYL) 6 METHYL 1,4 DIHYDROPYRIMIDINE 5 CARBOXYLATE; MONOMER; NUCLEOCAPSID PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LIGHT SCATTERING; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INHIBITION; VIRUS LOAD; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 52249120971     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.4.458     Document Type: Article

References (28)

1. Hepatitis B fact sheet no. 204. Geneva: World Health Organization, October 2000. [Online.] http://www.who.int/mediacentre/factsheets/fs204/ en/index. html
2. Liaw YF, Leung N, Guan R, Lau GK, Merican I. Asian-Pacific consensus statement on the management of chronic hepatitis B: an update. J Gastroenterol Hepatol 2003; 18:239-45.
3. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology 2001; 120:1828-53.
4. Lau GK, Piratvisuth T, Luo KX, Marcellin P, Thongsawat S, Cooksley G, et al. Peginterferon Alfa-2a, Lamivudine, and the Combination for HBeAg-Positive Chronic Hepatitis B. N Engl J Med 2005; 352:2682-95.
5. Marcellin P, Lau GK, Bonino F, Farci P, Hadziyanhis S, Jin R, et al. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg negative chronic hepatitis B. N Engl J Med 2004; 351:1206-17.
6. Dienstag JL, Schiff ER, Wright TL, Perrillo RP, Hann HW, Goodman Z, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 1999; 341:1256-63.
7. Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, et al. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003; 348:808-16.
8. Chang TT, Gish RG, de Man R, Gadano A, Sollano J, Chao YC, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B. N Engl J Med 2006; 354:1001-10.
9. Jones R, Nelson M. Novel anti-hepatitis B agents: A focus on telbivudine. Int J Clin Pract 2006; 60:1295-9.
10. Lim SG, Krastev Z, Ng TM, Mechkov G, Kotzev IA, Chan S, et al. Randomized, double-blind study of emtricitabine (FTC) plus clevudine versus FTC alone in treatment of chronic hepatitis B. Antimicrob Agents Chemother. 2006; 50: 1642-8.
11. Hoofnagle, J. H., Di Bisceglie A. M. The treatment of chronic viral hepatitis. N. Engl. J. Med 1997; 336:347-56.
12. Deres K Schroder CH Paessens A Goldmann S Hacker HJ Weber O et al. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science 2003; 299:893-6.
13. Weber O, Schlemmer KH, Hartmann E, Hagelschuer I, Paessens A, Graef. E, et al. Inhibition of human hepatitis B virus (HBV) by a novel non-nucleosidic compound in a transgenic mouse model. Antiviral Res 2002; 54: 69-78.
14. Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 51-68.
15. Stray SJ, Zlotnick A.BAY 41-4109 has multiple effects on Hepatitis B virus capsid assembly. J Mol Recognit. 2006; 19: 542-8.
16. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′,3′- dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991; 88:8495-9
17. Adam Zlotnick, Pablo Ceres, Sushmita Singh, and Jennifer M. Johnson. A Small Molecule Inhibits and Misdirects Assembly of Hepatitis B Virus Capsids. J Virol 2002; 76: 4848-54
18. Wieland SF, Eustaquio A, Whitten-Bauer C, Boyd B, Chisari FV. Interferon prevents formation of replication-competent hepatitis B virus RNA-containing nucleocapsids. Proc Natl Acad Sci USA. 2005 28:9913-7.
19. Wu GY, Chen HS. Novel approaches towards conquering hepatitis B virus infection. World J Gastroenterol. 2007; 6:830-6.
20. Loomba R, Liang TJ. Novel approaches to new therapies for hepatitis B virus infection. Antivir Ther 2006; 11:1-15.
21. Bottcher B,Wynne SA,Crowther RA. Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy. Nature 1997; 386: 88-91.
22. Watts NR, Conway JF, Cheng N, Stahl SJ, Belnap DM, Steven AC, et al. The morphogenic linker peptide of HBV capsid protein forms a mobile array on the interior surface. EMBO J 2002; 21:876-84.
23. Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, et al. New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and Relation between Levels of HBcAg and HBV DNA. J Clin Microbiol 2003; 41:1901-6.
24. McCaffrey A P, Nakai H, Pandey K, Huang Z, Salazar F H, Xu H, et al. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 2003; 21:639-44.
25. Sholomai A,Shaul Y. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology 2003; 37: 764-70.
26. Li Y, Fu L, Yeo H, Zhu JL, Chou CK, Kou YH, et al. Inhibition of hepatitis. B virus gene expression and replication by helioxanthin and its derivative. Antivir Chem Chemother 2005; 16:193-201.
27. Milich D, Liang TJ. Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology. 2003; 38:1075-86.
28. Stray SJ, Bourne CR, Punna S, Lewis WG, Finn MG, Zlotnick A. A heteroaryldihydropyrimidine activates and can misdirect hepatitis B virus capsid assembly. Proc Natl Acad Sci USA. 2005; 102: 8138-43.